![Kathryn Gregory](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn Gregory
Directeur/Membre du Conseil chez
DEVONIAN HEALTH GROUP INC.
Fortune : 225 $ au 31/05/2026
Profil
Kathryn J.
Gregory was the founder of Seneb Biosciences, Inc., founded in 2009, where the title held was Chief Executive & Business Officer from 2009 to 2017.
Current jobs include Independent Director at Devonian Health Group, Inc. starting in 2024, and Vice President & Head-Business Development at Rgenta Therapeutics, Inc. Former jobs include Executive Director-Business Development at Purdue Pharma LP from 2015 to 2017; Associate Director-Business Development at Gensia Sicor Pharmaceuticals, Inc. from 1988 to 1998; Director-Business Development at Cytel Corp.
from 1998 to 1999; Vice President-Business Development & Licensing at Neose Technologies, Inc. from 1999 to 2010; Vice President-Business Development at PhaseBio Pharmaceuticals, Inc.; Chief Business Officer & Senior Vice President at Rein Therapeutics, Inc.; Head-Transactions at Shire Pharmaceuticals, Inc. from 2012 to 2015; Head-North America Sourcing & Procurement at Teva Pharmaceuticals Ltd.; Chief Business Officer at Avillion LLP from 2017 to 2018; President at Kg Biopharma Consulting LLC from 2018 to 2019; Independent Director at Longevity Health Holdings, Inc. from 2021 to 2026; Vice President & Head-Business Development at Antengene Corp.
Ltd. from 2021 to 2023; and Chief Business Officer at ReVision Therapeutics, Inc. Education includes an MBA from Pepperdine University and undergraduate studies at the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2025 | 750 ( 0,03 % ) | 225 $ | 31/05/2026 | |
| 22/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Kathryn Gregory
| Sociétés | Poste | Début |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Directeur/Membre du Conseil | 28/02/2024 |
Rgenta Therapeutics, Inc.
 Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pipeline of oral and small-molecule RNA-targeting medicines | Corporate Officer/Principal | - |
Anciens postes connus de Kathryn Gregory
| Sociétés | Poste | Fin |
|---|---|---|
| LONGEVITY HEALTH HOLDINGS, INC. | Directeur/Membre du Conseil | 01/06/2026 |
| ANTENGENE CORPORATION LIMITED | Corporate Officer/Principal | 01/03/2023 |
Kg Biopharma Consulting LLC
 Kg Biopharma Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services | President | 01/02/2019 |
Avillion LLP
 Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Corporate Officer/Principal | 01/02/2018 |
Seneb Biosciences, Inc. | Directeur Général | 01/12/2017 |
Formation de Kathryn Gregory
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
ReVision Therapeutics, Inc.
 ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases | Retail Trade |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gensia Sicor Pharmaceuticals, Inc. | |
Cytel Corp. | |
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Avillion LLP
Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Health Technology |
Devonian Health Group, Inc.
 Devonian Health Group, Inc. Pharmaceuticals: MajorHealth Technology Develops botanical drugs | Health Technology |
Seneb Biosciences, Inc. | |
Kg Biopharma Consulting LLC
Kg Biopharma Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services | Commercial Services |
Rgenta Therapeutics, Inc.
Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pipeline of oral and small-molecule RNA-targeting medicines | Health Technology |
Antengene Corp. Ltd.
 Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
Carmell Therapeutics Corp.
 Carmell Therapeutics Corp. Financial ConglomeratesFinance Manufactures cosmetics | Finance |
Choisissez Zonebourse 
